MRNA EPS
Net income divided by diluted shares outstanding — the per-share profit earned each quarter.
Latest EPS: -$1.97 (2026Q2); +7.5% YoY.
Across the 14 quarters from 2023Q1 to 2026Q2, EPS ranged from -$9.53 in 2023Q3 to $0.56 in 2023Q4.
MRNA EPS
Latest: -$1.97 (2026Q2)
Healthcare Comparison
1 / 3
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 6
Revenue
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Rule of 40